Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
MRI Evaluation of Breast Tumor Growth and Treatment Response
Sponsor: National Cancer Institute (NCI)
A NA clinical study on Breast Cancer, this trial is completed. The trial is conducted by National Cancer Institute (NCI) and has accumulated 14 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2023 — Dec 2023 [monthly]
Active Not Recruiting NA
-
Dec 2021 — Jan 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 9 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Feb 2020 — Dec 2020 [monthly]
Active Not Recruiting NA
-
Jul 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2019 — Jul 2019 [monthly]
Recruiting NA
Status: Suspended → Recruiting
-
Aug 2018 — Mar 2019 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Vanderbilt-Ingram Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .